持续感染SARS-CoV-2的接受者的固体器官移植:对病例报告和系列的系统审查

持续感染SARS-CoV-2的接受者的固体器官移植:对病例报告和系列的系统审查

相关实验视频

Updated: Jun 15, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.3K

Andrea Lombardi¹, Marta Colaneri², Cecilia Azzarà³

¹Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Infectious Diseases Unit, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

|August 23, 2024

概括

在正在进行的SARS-CoV-2感染期间进行固体器官移植 (SOT) 是可行的. 研究表明,在适合,接种疫苗并患有轻度疾病的接受者中,没有COVID-19相关的死亡.

科学领域:

移植医学移植医学
传染性疾病传染性疾病
病毒学病毒学

背景情况:

在患有活跃SARS-CoV-2感染的患者中进行固体器官移植 (SOT) 的安全性仍然是一个重要的临床问题.
评估结果对于患者管理和手术决策至关重要.

研究的目的:

系统地审查和分析在正在进行的SARS-CoV-2感染的接受者中进行的SOT的结果.
在这个患者群体中评估故意SOT的安全性和可行性.

主要方法:

进行了系统的文献审查.
分析了29项涉及54名接受SOT同时感染SARS-CoV-2的接受者研究的数据.

主要成果:

腎臟移植是最常見的 (44.4%). 大多数接受者几乎没有并发症,并接种了COVID-19疫苗.
感染SARS-CoV-2和SOT之间的平均时间为16.1天.
虽然18.5%的患者需要氧气支持,13.7%的患者需要接受ICU治疗,但只有3.7%的患者因任何原因死亡,而没有与COVID-19相关的死亡.

结论:

在正在进行的SARS-CoV-2感染的非肺移植候选人中,可以安全地进行故意的SOT.
成功的结局与接受者健康,接种疫苗,并没有严重的疾病有关.
在这种情况下,研究结果表明COVID-19相关死亡风险较低.

关键词:

这就是Covid-19的原因.收件人收件人收件人这是SARS-Cov-2病毒.实体器官移植器官移植是什么

更多相关视频

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

7.8K

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.1K

相关概念视频

01:24

Tissue Transplantation

348

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

348

01:22

Bone Marrow Sampling and Transplants

316

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

316